Randomized, open label, multiple dose phase I study of the early bactericidal activity of linezolid, gatifloxacin, levofloxacin, and moxifloxacin in HIV-non-infected adults with initial episodes of sputum smear-positive pulmonary tuberculosis.

Trial Profile

Randomized, open label, multiple dose phase I study of the early bactericidal activity of linezolid, gatifloxacin, levofloxacin, and moxifloxacin in HIV-non-infected adults with initial episodes of sputum smear-positive pulmonary tuberculosis.

Completed
Phase of Trial: Phase I/II

Latest Information Update: 10 Jun 2010

At a glance

  • Drugs Gatifloxacin (Primary) ; Levofloxacin (Primary) ; Linezolid (Primary) ; Moxifloxacin (Primary) ; Isoniazid
  • Indications Pulmonary tuberculosis
  • Focus Therapeutic Use
  • Most Recent Events

    • 24 Jan 2008 Status change from in progress to completed.
    • 23 Jan 2008 The expected completion date for this trial is now 1 Nov 2007.
    • 14 Jan 2008 Status changed from recruiting to in progress.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top